[1]
|
X. D. Qu, R. Shrestha and M. D. Wang, “Risk Factors Analysis on Traumatic Brain Injury Prognosis,” Chinese Medical Sciences Journal, Vol. 26, No. 2, 2011, pp. 98-102. doi:10.1016/S1001-9294(11)60027-8
|
[2]
|
J. M. Simard, Z. Geng, S. K. Woo, S. Ivanova, et al., “Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage,” Journal of Cerebral Blood Flow & Metabolism, Vol. 29, No. 2, 2009, pp. 317-30.
doi:10.1038/jcbfm.2008.120
|
[3]
|
R. L. Wood and N. A. Rutterford, “Demographic and Cognitive Predictors of Long-Term Psychosocial Outcome Following Traumatic Brain Injury,” Journal of the International Neuropsychological Society, Vol. 12, No. 3, 2006, pp. 350-358. doi:10.1017/S1355617706060498
|
[4]
|
W. L. Titsworth, N. K. Liu and X. M. Xu, “Role of Secretory Phospholipase a(2) in CNS Inflammation: Implications in Traumatic Spinal Cord Injury,” CNS Neurological Disorders—Drug Targets, Vol. 7, No. 3, 2008, pp. 254-269. doi:10.2174/187152708784936671
|
[5]
|
X. Zhou, J. Zhou, X. Li, C. Guo, et al., “GSK-3β Inhibitors Suppressed Neuroinflammation in Rat Cortex by Activating Autophagy in Ischemic Brain Injury,” Biochemical and Biophysical Research Communications, Vol. 411, No. 2, 2011, pp. 271-275.
doi:10.1016/j.bbrc.2011.06.117
|
[6]
|
S. S. Dai and Y. G. Zhou, “Adenosine 2A Receptor: A Crucial Neuromodulator with Bidirectional Effect in Neuroinflammation and Brain Injury,” Review in the Neuroscience, Vol. 22, No. 2, 2011, pp. 231-239.
doi:10.1515/RNS.2011.020
|
[7]
|
Y. Deng, W. Fang, Y. Li, et al., “Blood-Brain Barrier Breakdown by PAF and Protection by XQ-1H Due to Antagonism of PAF Effects,” European Journal of Pharmacology, Vol. 616, No. 1-3, 2009, pp. 43-47.
doi:10.1016/j.ejphar.2009.06.017
|
[8]
|
T. Tokutomi, H. Maruiwa, M. Hirohata, et al., “Production of Platelet-Activating Factor by Neuronal Cells in the Rat Brain with Cold Injury,” Neurological Research, Vol. 23, No. 6, 2001, pp. 605-611.
doi:10.1179/016164101101199081
|
[9]
|
H. S. Lustig, J. Chan and D. A. Greenberg, “Comparative Neurotoxic Potential of Glutamate, Endothelins, and Platelet-Activating Factor in Cerebral Cortical Cultures,” Neuroscience Letters, Vol. 139, No. 1, 1992, pp. 15-18.
doi:10.1016/0304-3940(92)90847-Z
|
[10]
|
S. Ishii and T. Shimizu, “Platelet-Activating Factor (PAF) Receptor and Genetically Engineered PAF Receptor Mutant Mice,” Progress in Lipid Research, Vol. 391, 2000, pp. 41-48. doi:10.1016/S0163-7827(99)00016-8
|